Fund Action speaks to retail industry experts about the challenges related to collecting, structuring and extracting actionable insights from data. Alexey Utkin, Principal Solution Consultant in the Finance Practice at DataArt, highlights the importance of creating prominent positions for data management and data analytics roles.
Buying Business Travel Magazine presents an overview of expert opinions on the adoption of facial recognition technology in various travel scenarios, including biometric self-boarding and security screening. Charlotte Lamp Davies, Vice President of Travel & Hospitality at DataArt Europe, shares her insight on how a personalized hotel guest experience can be further enhanced with the new technologies.
Euro Pharma Mag runs the announcement of DataArt winning the 2017 Pfizer Healthcare Challenge award in Munich.
PhocusWirePundIT Show features Charlotte Lamp Davis, Vice President of Travel & Hospitality at DataArt, alongside Alex Kremer, co-founder of Redeam, and Sam Shank, CEO of HotelTonight, commenting on highlights of the PhocusWright Conference and the most important developments in travel.
The announcement of DataArt winning the 2017 Pfizer Healthcare Challenge award in Munich is covered by Pharma Relations, Germany’s leading healthcare and pharma magazine.
Founder Magazine runs the announcement of DataArt winning the 2017 Pfizer Healthcare Challenge award in Munich.
In Towards Data Science, Sergey Bludov, SVP in Media and Entertainment Practice at DataArt, explores the advances of artificial intelligence in the music ecosystem.
Fintech Finance Magazine covers the announcement of a blockchain event to be hosted by DataArt and management consultancy zeb in Munich on Nov. 22 where leading fintech and blockchain experts will discuss real-life examples of blockchain implementation.
In Plattform Life Sciences, a German life sciences journal, Anton Dolgikh, Head of AI at DataArt, discusses the role of artificial intelligence in clinical trials, namely its significant impact on targets search, hits/leads search, adverse effects reduction, and old drugs repositioning.